Epic Sciences Garners $30,000,000 Series C Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bcdd0cd7-5725-4cb8-a660-a65e4a1b69c2
Date
7/30/2014
Company Name
Epic Sciences
Mailing Address
9381 Judicial Drive La Jolla, CA 92121 USA
Company Description
We develop new, highly sensitive diagnostic tests that identify and molecularly characterize circulating tumor cells (CTCs) in the blood to provide a better way to detect cancer and personalize and monitor treatments.
Website
http://www.epicsciences.com
Transaction Type
Venture Equity
Transaction Amount
$30,000,000
Transaction Round
Series C
Proceeds Purposes
With the proceeds of the financing, Epic will commercialize its circulating rare cell analysis platform with special focus on developing products and services to detect circulating tumor cells (CTC) in cancer.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor